Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

A Rhode Island House committee heard powerful testimony from cancer survivors on a bill that would require insurance ...

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

New York City Health + Hospitals/South Brooklyn Health unveiled a $2 million expansion of its Oncology and Infusion Center, ...

The University of Iowa Health Care Holden Comprehensive Cancer Center has started treating its second patient — the second in the state — with a cellular therapy to fight synovial sarcoma, a rare and ...

In the fight against leukemia, even the most advanced treatments carry a significant risk of the disease returning. Now, Chinese scientists have developed a kind of "double-sided tape" that helps the ...

Geisinger’s $32 million cancer center along Route 15 in East Buffalo Township is expected to open by August. Officials from the Danville-based health care system and Harrisburg-based ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

If you decide to invest in this company, it's probably best to start small.